Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Obese Japanese adults with type 2 diabetes have higher basal metabolic rates than non-diabetic adults.

Miyake R, Ohkawara K, Ishikawa-Takata K, Morita A, Watanabe S, Tanaka S.

J Nutr Sci Vitaminol (Tokyo). 2011;57(5):348-54.

3.

Increased 24-h energy expenditure in type 2 diabetes.

Bitz C, Toubro S, Larsen TM, Harder H, Rennie KL, Jebb SA, Astrup A.

Diabetes Care. 2004 Oct;27(10):2416-21.

PMID:
15451910
4.

Platelet count is independently associated with insulin resistance in non-obese Japanese type 2 diabetic patients.

Taniguchi A, Fukushima M, Seino Y, Sakai M, Yoshii S, Nagasaka S, Yamauchi I, Okumura T, Nin K, Tokuyama K, Yamadori N, Ogura M, Kuroe A, Nakai Y.

Metabolism. 2003 Oct;52(10):1246-9.

PMID:
14564674
5.

In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension.

Bonora E, Bonadonna RC, Del Prato S, Gulli G, Solini A, Matsuda M, DeFronzo RA.

Diabetes. 1993 May;42(5):764-72.

PMID:
8482434
6.

Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients.

Taniguchi A, Nakai Y, Sakai M, Yoshii S, Hamanaka D, Hatae Y, Kawata M, Yamanouchi K, Okumura T, Doi K, Tokuyama K, Nagasaka S, Fukushima M.

Metabolism. 2002 May;51(5):544-8.

PMID:
11979383
7.

Postprandial hyperlipidemia after a fat loading test in minority adolescents with type 2 diabetes mellitus and obesity.

Umpaichitra V, Banerji MA, Castells S.

J Pediatr Endocrinol Metab. 2004 Jun;17(6):853-64.

PMID:
15270403
9.

Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus.

Al-Harithy RN, Al-Ghamdi S.

Ann Saudi Med. 2005 Jul-Aug;25(4):283-7.

10.

Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy.

Putz DM, Goldner WS, Bar RS, Haynes WG, Sivitz WI.

Metabolism. 2004 Nov;53(11):1454-61.

PMID:
15536601
11.

Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes.

Levin K, Daa Schroeder H, Alford FP, Beck-Nielsen H.

Diabetologia. 2001 Jul;44(7):824-33.

PMID:
11508266
13.

Bromocriptine: a novel approach to the treatment of type 2 diabetes.

Pijl H, Ohashi S, Matsuda M, Miyazaki Y, Mahankali A, Kumar V, Pipek R, Iozzo P, Lancaster JL, Cincotta AH, DeFronzo RA.

Diabetes Care. 2000 Aug;23(8):1154-61.

14.

Resting energy expenditure is not increased in mildly hyperglycaemic obese diabetic patients.

Ryan M, Sallé A, Guilloteau G, Genaitay M, Livingstone MB, Ritz P.

Br J Nutr. 2006 Nov;96(5):945-8.

PMID:
17092386
15.

Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).

El-Mesallamy HO, Hamdy NM, Salman TM, Mahmoud S.

Minerva Endocrinol. 2011 Sep;36(3):163-70.

PMID:
22019747
16.

Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.

Chung JW, Suh KI, Joyce M, Ditzler T, Henry RR.

Diabetes Care. 1995 May;18(5):666-73.

PMID:
8586004
18.

The associations of body mass index, C-peptide and metabolic status in Chinese Type 2 diabetic patients.

Chan WB, Tong PC, Chow CC, So WY, Ng MC, Ma RC, Osaki R, Cockram CS, Chan JC.

Diabet Med. 2004 Apr;21(4):349-53.

PMID:
15049937
19.

The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes.

Tong PC, Lee ZS, Sea MM, Chow CC, Ko GT, Chan WB, So WY, Ma RC, Ozaki R, Woo J, Cockram CS, Chan JC.

Arch Intern Med. 2002 Nov 25;162(21):2428-35.

PMID:
12437401
20.

Increased BMR in overweight and obese patients with type 2 diabetes may result from an increased fat-free mass.

Sun MX, Zhao S, Mao H, Wang ZJ, Zhang XY, Yi L.

J Huazhong Univ Sci Technolog Med Sci. 2016 Feb;36(1):59-63. doi: 10.1007/s11596-016-1542-6. Epub 2016 Feb 3.

PMID:
26838741

Supplemental Content

Support Center